Previously studies have correlated plasma HGF levels with MM clinical parameters such as diagnosis[20-23] disease stage, aggressiveness[22,24,25], prognosis[22,23,26], and response[26-29]. This evidence concerns the gene HGF and Miyoshi myopathy.